Nexalin Technology Inc. (NXL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nexalin Technology Inc. (NXL) has a cash flow conversion efficiency ratio of -0.593x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.71 Million) by net assets ($2.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NXL company net worth for the company's overall valuation and market capitalisation.
Nexalin Technology Inc. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Nexalin Technology Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nexalin Technology Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nexalin Technology Inc. ranked by their cash flow conversion efficiency. See NXL cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Patriot Resources Ltd
AU:PAT
|
0.050x |
|
Triboron International AB (publ)
ST:TRIBO-B
|
0.092x |
|
Innovative Eyewear Inc.
NASDAQ:LUCY
|
-0.270x |
|
Peraso Inc
NASDAQ:PRSO
|
-0.320x |
|
Companhia Paranaense de Energia Pref ADR
NYSE:ELP
|
0.030x |
|
Global Engine Group Holding Limited Ordinary Shares
NASDAQ:GLE
|
-0.124x |
|
Nutritional Growth Solutions Ltd
AU:NGS
|
-0.240x |
|
Rockhopper Exploration
LSE:RKH
|
0.069x |
Annual Cash Flow Conversion Efficiency for Nexalin Technology Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Nexalin Technology Inc. from 2019 to 2025. View NXL stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.75 Million | $-4.96 Million | -1.323x | -23.28% |
| 2024-12-31 | $3.68 Million | $-3.94 Million | -1.073x | +10.29% |
| 2023-12-31 | $3.21 Million | $-3.84 Million | -1.196x | -195.75% |
| 2022-12-31 | $5.48 Million | $-2.22 Million | -0.404x | -163.17% |
| 2021-12-31 | $-1.68 Million | $-1.08 Million | 0.640x | +17.91% |
| 2020-12-31 | $-1.59 Million | $-863.47K | 0.543x | -5.60% |
| 2019-12-31 | $-1.18 Million | $-678.34K | 0.575x | -- |
About Nexalin Technology Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 a… Read more